Expertise in
15
conditions

Jie Q. Ma

No 127, Dongming Road, 
Zhengzhou, CN 
Expertise in
15
conditions
No 127, Dongming Road, 
Zhengzhou, CN 

Overview

Jie Ma practices practicing medicine in Zhengzhou, China.

Ma is highly rated in 15 conditions, according to our data. Their clinical expertise encompasses Squamous Cell Lung Carcinoma, Lung Adenocarcinoma, Lung Cancer, and EGFR Positive Lung Cancer.

They are actively involved in clinical research, co-authoring 676 peer reviewed articles and participating in 2 clinical trials.

Locations

No 127, Dongming Road, Zhengzhou, 450008, China
Other Locations
6 Shuangyong Road, Nanning, 530021, China
28 Fuxing Road, Haidian, 100853, China
No. 139 Middle Renmin Road, Changsha, 410011, China
No. 100 Kexue Road, Zhengzhou, 450001, China
28 West Xianning Street, Xi'an, 710000, China
No.1, East Jianshe Road, Zhengzhou, 450052, China
30 Shuang Qing Road, Beijing, 100084, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Controlled, Open-label, Multicenter Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride Capsules Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC)
A Randomized, Controlled, Open-label, Multicenter Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride Capsules Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC)
Enrollment Status: Active_not_recruiting
Publish Date: February 20, 2025
Intervention Type: Drug
Study Drugs: AK105 Injection, Anlotinib Hydrochloride Capsules, Sorafenib Tosylate Tablets
Study Phase: Phase 3
An Open, Single-center, Phase II Study of Sintilimab, Peg-aspargase Plus Anlotinib SandwichWith Radiotherapy in Previously Untreated Stage I-II Extranodal NK/T Cell Lymphoma
An Open, Single-center, Phase II Study of Sintilimab, Peg-aspargase Plus Anlotinib SandwichWith Radiotherapy in Previously Untreated Stage I-II Extranodal NK/T Cell Lymphoma
Enrollment Status: Completed
Publish Date: June 09, 2022
Intervention Type: Drug
Study Drug: Sintilimab
Study Phase: Phase 2
View 1 Less Clinical Trial

676 Total Publications

An individualized nomogram for predicting progression-free survival in systemic anaplastic large cell lymphoma: a multicenter, retrospective, and internally validated study.
An individualized nomogram for predicting progression-free survival in systemic anaplastic large cell lymphoma: a multicenter, retrospective, and internally validated study.
Journal: Hematology (Amsterdam, Netherlands)
Published: August 12, 2026

Frequently Asked Questions about Jie Q. Ma

Is Jie Q. Ma a top-rated expert for Squamous Cell Lung Carcinoma?

MediFind is an objective health platform that identifies experts based on real-world data. Jie Q. Ma is classified as an Advanced expert for Squamous Cell Lung Carcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jie Q. Ma participate in research or clinical trials?

Yes. Jie Q. Ma has published 676 articles and abstracts on conditions like Squamous Cell Lung Carcinoma. You can view a list of Jie Q. Ma's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ma's expertise for a condition
ConditionClose
      View All 15 Advanced Conditions
      View All 119 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile